Fenge Li

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Genetic Engineering of Tumor-Infiltrating Lymphocytes (TIL) via a T-Editor Platform to Enhance Anti-Tumor Activity.

Genetic Engineering of Tumor-Infiltrating Lymphocytes (TIL) via a T-Editor Platform to Enhance Anti-Tumor Activity.

Journal: Cancer science

Published: April 14, 2026

T cell receptor repertoire dynamics and newly identified functional regulators of autologous tumor-infiltrating lymphocyte therapy in advanced solid tumors.

T cell receptor repertoire dynamics and newly identified functional regulators of autologous tumor-infiltrating lymphocyte therapy in advanced solid tumors.

Journal: Journal of translational medicine

Published: March 24, 2026

Multiple autologous tumor-infiltrating lymphocyte (LM103 infusion) therapy combined with immune checkpoint inhibitor induces repeated tumor regression in a patient with aggressive mucosal melanoma: a case report and literature review.

Multiple autologous tumor-infiltrating lymphocyte (LM103 infusion) therapy combined with immune checkpoint inhibitor induces repeated tumor regression in a patient with aggressive mucosal melanoma: a case report and literature review.

Journal: Frontiers in oncology

Published: January 16, 2026

Next generation sequencing guided treatment of ALK tyrosine kinase inhibitor induced long survival in lung squamous cell carcinoma harboring ROS1 gene fusions: a case report and literature review.

Next generation sequencing guided treatment of ALK tyrosine kinase inhibitor induced long survival in lung squamous cell carcinoma harboring ROS1 gene fusions: a case report and literature review.

Journal: Frontiers in medicine

Published: December 19, 2025

Single-Cell Dissection of Tumor-Infiltrating Lymphocytes Reveals Cellular Architecture Predictive of Therapeutic Efficacy in Acral Melanoma.

Single-Cell Dissection of Tumor-Infiltrating Lymphocytes Reveals Cellular Architecture Predictive of Therapeutic Efficacy in Acral Melanoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 30, 2025

Methanobrevibacter smithii activates immune microenvironment of intestinum tenue in a mouse model.

Methanobrevibacter smithii activates immune microenvironment of intestinum tenue in a mouse model.

Journal: Archives of microbiology

Published: October 15, 2025

Clinical and Fundamental Research Progressions on Tumor-Infiltrating Lymphocytes Therapy in Cancer.

Clinical and Fundamental Research Progressions on Tumor-Infiltrating Lymphocytes Therapy in Cancer.

Journal: Vaccines

Published: March 19, 2025

Evolving role of deubiquitinating enzymes in oral cancer (Review).

Evolving role of deubiquitinating enzymes in oral cancer (Review).

Journal: Oncology letters

Published: December 03, 2024

Nicotinamide adenine dinucleotide alleviates neuroinflammation in rats with traumatic brain injury.

Nicotinamide adenine dinucleotide alleviates neuroinflammation in rats with traumatic brain injury.

Journal: Neuroscience letters

Published: November 22, 2024

Prognostic significance of peripheral and tumor-infiltrating lymphocytes in newly diagnosed stage III/IV non-small-cell lung cancer.

Prognostic significance of peripheral and tumor-infiltrating lymphocytes in newly diagnosed stage III/IV non-small-cell lung cancer.

Journal: Frontiers in medicine

Published: December 04, 2023

Autologous Tumor-Infiltrating Lymphocyte Mono-Therapy Can Rapidly Shrank Tumor in Asian Patient with Stage III/IV Cervical Cancer: Two Cases Report.

Autologous Tumor-Infiltrating Lymphocyte Mono-Therapy Can Rapidly Shrank Tumor in Asian Patient with Stage III/IV Cervical Cancer: Two Cases Report.

Journal: International journal of women's health

Published: October 26, 2023

Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma.

Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma.

Journal: Vaccines

Published: July 29, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026